[Frequency of recurrence following successful balloon dilatation of coronary artery stenoses]

Zeitschrift Fur Kardiologie
|January 1, 1984
PubMed

Insights

This study analyzed follow-up angiograms after successful percutaneous transluminal coronary angioplasty (PTCA), finding a restenosis rate of 12-17%. Medical treatment, particularly acetylsalicylic acid, nitrates, and calcium blockers, may contribute to this low rate.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure for treating coronary artery stenosis.
  • Restenosis, the re-narrowing of the artery after PTCA, remains a significant challenge.
  • Understanding factors influencing restenosis rates is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the restenosis rates following successful PTCA.
  • To identify potential factors contributing to the observed restenosis rates.
  • To assess the impact of medical management on restenosis after PTCA.

Main Methods:

  • Analysis of 439 follow-up angiograms from 333 patients who underwent successful PTCA between 1977 and 1983.
  • Restenosis was defined using three different criteria, including luminal narrowing and loss of initial diameter increase.
  • Patient subgroups, such as those undergoing repeat PTCA or bypass stenosis dilatation, were analyzed separately.

Main Results:

  • Restenosis rates varied from 12% to 17% depending on the definition used.
  • Excluding patients with repeat PTCA or bypass stenosis dilatation, the restenosis rate was 15.4%.
  • Restenosis rates were significantly higher in subgroups undergoing repeat PTCA (33%) and bypass stenosis dilatation (45%).

Conclusions:

  • A relatively low restenosis rate was observed following successful PTCA.
  • Factors such as patient selection, PTCA technique, and medical treatment likely influence restenosis.
  • Chronic medical treatment with high-dose aspirin, nitrates, and calcium blockers is considered a primary contributor to the favorable outcome.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...